Live Breaking News & Updates on Yi Bao

Stay updated with breaking news from Yi bao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively

The Proportion of Revenue from Innovative Products Continues to Increase Highlights: Revenue for the year ended December 31, 2021 was RMB39,005 million,. ....

South Sudan , United States , Hong Kong , Han Li Kang Rituximab , Yi Bao , Wanbang Biopharm , Yao Pharma , Wu Yifang , Fosun Pharma , Axicabtagene Ciloleucel , Guilin Pharma , Xin Avatrombopag , Han Li Kang , Sinopharm Co Ltd , Shanghai Fosun Pharmaceutical Group Co Ltd , Vaccines Division , Innovation For Good Health , Innovative Medicines Division , National Medical Products Administration , Medicines Manufacturing Supply Division , Rating Expert Committee , Innovative Products Continues , Mainland China , Han Qu You , Shanghai Fosun Pharmaceutical , Stock Code ,